Hepatitis C: What have been our successes so far?

Jul 26, 2017

Discussion on hepatitis C infection with focus on treatment advancements using oral direct-acting agents. Topics include transmission, testing procedures, genotype relevance, post-treatment considerations, advanced liver disease treatment, and long-term effects of antiviral treatment.

Ask episode

Chapters

Transcript

Episode notes

Introduction

00:00 • 2min

Understanding Hepatitis C Antibodies, Treatment Advancements, and Genotype Relevance

02:12 • 3min

Post-Treatment Considerations for Hepatitis C with Direct Acting Agents

05:06 • 2min

Treatment of Advanced Liver Disease and Long-Term Effects of Antiviral Treatment for Hepatitis C

07:03 • 3min

Following acute exposure to the hepatitis C virus, most people develop chronic infection that increases the risk for long-term hepatic complications. Current treatment with oral direct-acting agents aims to eradicate the virus. Jawad Ahmad, Professor of Medicine in the Division of Liver Diseases at The Mount Sinai Hospital in New York, discusses hepatitis C infection with BMJ Knowledge Centre's U.S. Clinical Lead Sheila Feit, including future directions for a rapidly evolving field. More information available at the BMJ Best Practice website: http://bestpractice.bmj.com. About BMJ Best Practice BMJ Best Practice takes you quickly and accurately to the latest evidence based information, whenever and wherever you need it. Our step by step guidance on diagnosis, prognosis, treatment and prevention is updated daily using robust evidence based methodology and expert opinion. We support you in implementing good practice. Sign up to a free 7 day trial here*: bestpractice.bmj.com/info/subscribe/free-trial/ The below topics will be made freely available for 2 weeks from World Hepatitis Day (28th July 2017): Hepatitis C Step-by-step management: http://bestpractice.bmj.com/best-practice/monograph/128/treatment/details.html Treatment guidelines including American Association for the Study of Liver Diseases (AASLD) and European Association for Study of the Liver (EASL) http://bestpractice.bmj.com/best-practice/monograph/128/treatment/guidelines.html Hepatitis C Clinical Update in The BMJ (free access until 10th August 2017) http://www.bmj.com/content/358/bmj.j2861 *Please note that free personal trials and personal subscriptions are not available in North America. _

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.